• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过在低纳米颗粒与细胞比例下的单粒子追踪,实现荧光标记脂质纳米颗粒与特异性标记的亚细胞区室的共定位。

Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.

作者信息

Tiffany Matthew, Szoka Francis C

机构信息

a Department of Bioengineering, Therapeutic Sciences and Pharmaceutical Chemistry , University of California , San Francisco , CA , USA.

b Department of Pediatrics and Genetics , Stanford University School of Medicine , Stanford , CA , USA.

出版信息

J Drug Target. 2016 Nov;24(9):857-864. doi: 10.1080/1061186X.2016.1233976. Epub 2016 Sep 30.

DOI:10.1080/1061186X.2016.1233976
PMID:27600702
Abstract

We utilized quantitative high-resolution single particle tracking to study the internalization and endosomal sorting of lipid nanoparticles (LNPs) by HeLa cells in vitro to gain a better understanding of how cells process LNPs that are used for siRNA delivery. We compared the trafficking of three formulations that have been demonstrated to deliver siRNA into cells. They were composed of either a tritratable anionic lipid, formulation of cholesterol hemisuccinate (CHEMS), or a titratatable cationic lipid formulation of 1,2-dilinoleyloxy-3-dimethylaminopropane (DLinDMA) or a non-titratable cationic formulation lipid formulation of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). They also contained either a substantial percentage of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) or cholesterol and 5 mole percent 1,2-dimyristoyl-sn-glycerol-[methoxy(polyethylene glycol)-2000 (PEG-DMG). We optically measured the endosomal pH experienced by individual LNPs, observed the internalization pathways used and tracked the particles as they co-localized with fluorescent protein tags on compartment-specific proteins, during endosomal sorting to the lysosome. The data revealed significant differences in the accumulation in subcellular compartments among the three formulations, which help to explain the observed effects LNP composition exerts on in vitro delivery efficiency.

摘要

我们利用定量高分辨率单粒子追踪技术,在体外研究脂质纳米颗粒(LNP)被HeLa细胞内化和内体分选的过程,以更好地了解细胞如何处理用于递送小干扰RNA(siRNA)的LNP。我们比较了三种已被证明能将siRNA递送至细胞内的制剂的运输情况。它们分别由可滴定的阴离子脂质胆固醇半琥珀酸酯(CHEMS)制剂、可滴定的阳离子脂质1,2-二亚油酰氧基-3-二甲基氨基丙烷(DLinDMA)制剂或不可滴定的阳离子脂质1,2-二油酰基-3-三甲基铵丙烷(DOTAP)制剂组成。它们还分别含有相当比例的1,2-二油酰基-sn-甘油-3-磷酸乙醇胺(DOPE)或胆固醇以及5摩尔百分比的1,2-二肉豆蔻酰-sn-甘油-[甲氧基(聚乙二醇)-2000](PEG-DMG)。我们通过光学方法测量了单个LNP所经历的内体pH值,观察了其使用的内化途径,并在LNP内体分选至溶酶体的过程中,追踪了与特定区室蛋白上的荧光蛋白标签共定位的颗粒。数据显示,这三种制剂在亚细胞区室中的积累存在显著差异,这有助于解释所观察到的LNP组成对体外递送效率的影响。

相似文献

1
Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.通过在低纳米颗粒与细胞比例下的单粒子追踪,实现荧光标记脂质纳米颗粒与特异性标记的亚细胞区室的共定位。
J Drug Target. 2016 Nov;24(9):857-864. doi: 10.1080/1061186X.2016.1233976. Epub 2016 Sep 30.
2
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.脂质-聚合物杂化纳米颗粒作为新一代治疗性递送平台:综述
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
3
Peptide-based targeted polymeric nanoparticles for siRNA delivery.基于肽的靶向聚合物纳米颗粒用于 siRNA 递送。
Nanotechnology. 2019 Oct 11;30(41):415604. doi: 10.1088/1361-6528/ab313d. Epub 2019 Jul 11.
4
Optimization of Lipid Nanoformulations for Effective mRNA Delivery.脂质纳米制剂的优化用于有效 mRNA 递送。
Int J Nanomedicine. 2022 Jul 2;17:2893-2905. doi: 10.2147/IJN.S363990. eCollection 2022.
5
Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.DOTAP/胆固醇阳离子脂质纳米粒用于 mRNA、pDNA 和寡核苷酸递药的优化。
AAPS PharmSciTech. 2022 May 9;23(5):135. doi: 10.1208/s12249-022-02294-w.
6
Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.壳聚糖脂质纳米粒(CS-LNPs):在 siRNA 递送中的应用。
J Colloid Interface Sci. 2018 Jan 15;510:45-56. doi: 10.1016/j.jcis.2017.09.045. Epub 2017 Sep 11.
7
Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.阳离子两亲性大分子 (CAM)-脂质复合物用于高效的 siRNA 基因沉默。
J Control Release. 2014 Jun 28;184:28-35. doi: 10.1016/j.jconrel.2014.04.005. Epub 2014 Apr 13.
8
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.优化用于体内 mRNA 传递的脂质纳米粒子配方:基于部分因子和确定筛设计。
Nano Lett. 2015 Nov 11;15(11):7300-6. doi: 10.1021/acs.nanolett.5b02497. Epub 2015 Oct 20.
9
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.辅助脂质在用于寡核苷酸递送的脂质纳米颗粒(LNP)中的作用。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):129-137. doi: 10.1016/j.addr.2016.01.022. Epub 2016 Feb 18.
10
Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging.新型脂质包覆磁性纳米粒子的制剂作为体内成像的探针。
J Biomed Sci. 2009 Sep 21;16(1):86. doi: 10.1186/1423-0127-16-86.

引用本文的文献

1
Nanoscopy for endosomal escape quantification.用于内体逃逸定量分析的纳米显微镜技术。
Nanoscale Adv. 2020 Oct 27;3(1):10-23. doi: 10.1039/d0na00454e. eCollection 2021 Jan 7.
2
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics.监管指南和临床前工具研究 RNA 治疗药物的生物分布。
Adv Drug Deliv Rev. 2022 May;184:114236. doi: 10.1016/j.addr.2022.114236. Epub 2022 Mar 26.